1 / 11

ION-SELECTIVE CLINICAL LAB ANALYZERS MARKET ANALYSIS

Read here the report.

PriyaCmi
Download Presentation

ION-SELECTIVE CLINICAL LAB ANALYZERS MARKET ANALYSIS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

  2. ION-SELECTIVE CLINICAL LAB ANALYZERS MARKET ANALYSIS Ion-Selective Clinical Lab Analyzers Market, By Product Type (Ion–selective Membranes, Ion–selective Electrodes, Reagents, and Disposables), By Application (Clinical Chemistry, Hematology, Urine Analysis, and Others), By End User (Hospitals, Diagnostics Centers, Pharmaceutical and Biotechnology Companies, Academics and Research Centres), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  3. Market Drivers Leading manufacturers in the global ion-selective clinical lab analyzers market are focused on the development of products. For instance, Erba Mannheim launched EC90, a new electrolyte analyzer in February 2020 at the MEDLAB Middle East trade fair. The EC90 analyzer contains maintenance free electrode, cleaning of the pack is not required, and waste is self-contained. Moreover, it can analyze samples in 35 seconds. Other advantages of using ion selective electrodes over other methods are that they can be used for a sample size of 0.1 to 10,000 ppm. Moreover, they are shock-proof and chemical-resistant, upon calibration, and one can monitor concentration continuously and analyze the sample within 1 to 2 minutes. The above factors are expected to drive the global ion selective clinical lab analyzers market growth over the forecast period.

  4. Market Restraints Manufacturers are focused on modifying conventional ISE in order to reduce the drawbacks of the technique which include the selective membrane used in the ISE, which can allow the entry of more than one type of ion at a time, and the electrodes have to be replaced periodically. Moreover, ISE calculates ions when they move across the membrane. In case of dilute solution the number of ions near the membrane would be less than the ions present in the bulk solution. Therefore, the membrane potential recorded may get altered in both the cases.

  5. Market Opportunities • North America is expected to dominate the global ion-selective clinical lab analyzers market over the forecast period as manufacturers are focused on the development and introduction of ion selective clinical lab analyzers in the North American region. For instance, Thermo Fisher Scientific Inc. launched a premium Thermo Scientific Orion Ammonia Ion Selective Electrode in 2018. The new electrode can detect ions in low concentration as it is sensitive to ions and requires less electrode maintenance. It is an ideal product to use in drinking water and wastewater laboratories. • Moreover, Beckman Coulter Diagnostics received U.S. FDA approval for its DxC 700 AU Chemistry Analyzer in 2017. The DxC 700 AU system was initially available in the U.S. before 2017. Abbott Point of Care Inc.'s product i-STAT which is a handheld device, can perform blood analysis in four steps. The advantage of i-STAT over benchtop analyzers is that it provides faster results. The above factors are expected to boost the global ion – selective clinical lab analyzers market growth over the forecast period.

  6. Key Players • Some of the key players operating in the global ion–selective clinical lab analyzers market are Thermo Fisher Scientific Inc., Van London Company, Abbott Point of Care Inc., Beckman Coulter, Inc., DiagnostikaPilipinas Inc. F. Hoffmann-La Roche Ltd, ECD, Alfa Wassermann Inc., Pointe Scientific, Inc., Metrohm AG, and Medica Corporation. • Market Taxonomy • Based on Product Type, the global ion–selective clinical lab analyzers market is segmented into: • Ion –Selective Membranes • Ion – Selective Electrodes • Reagents • Disposables

  7. Based on Application, the global ion–selective clinical lab analyzers market is segmented into: • Clinical Chemistry • Hematology • Urine Analysis • Others • Based on End User, the global ion–selective clinical lab analyzers market is segmented into: • Hospitals • Diagnostics Centers • Pharmaceutical and Biotechnology Companies • Academics and Research Centres • Africa

  8. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst • Buy Now Reference : https://www.coherentmarketinsights.com/ongoing-insight/ion-selective-clinical-lab-analyzers-market-3461

  9. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  10. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

  11. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/

More Related